Literature DB >> 20140303

DNA damage and related modifier genes in Italian cystic fibrosis patients.

Silvia Sterpone1, Tommaso Cornetta, Adriano Angioni, Ersilia Fiscarelli, Vincenzina Lucidi, Antonella Testa, Renata Cozzi.   

Abstract

Cystic Fibrosis (CF) is an autosomal recessive multisystemic disorder showing a highly heterogeneous phenotype, even among siblings carrying identical CFTR mutations. Moreover, oxidative stress is of central importance in the pathogenesis of cystic fibrosis. The present study seeks to value the presence of oxidative damage in CF patients and the possible modifier effect of repair and glutathione-S-transferase genes. We analysed the presence of DNA damage in leukocytes of 63 CF patients at an Italian CF centre and 63 controls, through the alkaline Comet assay to detect DNA strand breaks. Furthermore, controls and 93 CF subjects were genotyped for 5 genes by RFLP-PCR (XRCC1,0GG1,GSTP1) and PCR assay (GSTM1, GSTT1). No difference in Comet assay values was observed comparing controls to CF patients, although CF subjects showed slightly higher mean values. The crude Odds-Ratio (OR) was higher than one for XRCC1 and GSTP1 genotypes and liver status and for XRCC1 and OGG1 genotypes and pancreatic insufficiency, but in all cases the p-values were not significant. In this case-control study, neither DNA damage ñor gene polymorphisms seem to influence CF manifestation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140303     DOI: /S0716-97602009000400009

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  3 in total

1.  Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.

Authors:  A Osorio; R L Milne; R Alonso; G Pita; P Peterlongo; A Teulé; K L Nathanson; S M Domchek; T Rebbeck; A Lasa; I Konstantopoulou; F B Hogervorst; S Verhoef; M F van Dooren; A Jager; M G E M Ausems; C M Aalfs; C J van Asperen; M Vreeswijk; Q Waisfisz; C E Van Roozendaal; M J Ligtenberg; D F Easton; S Peock; M Cook; C T Oliver; D Frost; B Curzon; D G Evans; F Lalloo; R Eeles; L Izatt; R Davidson; J Adlard; D Eccles; K-r Ong; F Douglas; S Downing; C Brewer; L Walker; H Nevanlinna; K Aittomäki; F J Couch; Z Fredericksen; N M Lindor; A Godwin; C Isaacs; M A Caligo; N Loman; H Jernström; G Barbany-Bustinza; A Liljegren; H Ehrencrona; M Stenmark-Askmalm; L Feliubadaló; S Manoukian; B Peissel; D Zaffaroni; B Bonanni; S Fortuzzi; O T Johannsson; G Chenevix-Trench; X-C Chen; J Beesley; A B Spurdle; O M Sinilnikova; S Healey; L McGuffog; A C Antoniou; J Brunet; P Radice; J Benítez
Journal:  Br J Cancer       Date:  2011-03-22       Impact factor: 7.640

2.  Genetic interaction of GSH metabolic pathway genes in cystic fibrosis.

Authors:  Fernando Augusto de Lima Marson; Carmen Sílvia Bertuzzo; Rodrigo Secolin; Antônio Fernando Ribeiro; José Dirceu Ribeiro
Journal:  BMC Med Genet       Date:  2013-06-10       Impact factor: 2.103

3.  Deoxyribonucleic acid repair gene X-ray repair cross-complementing group 1 polymorphisms and non-carcinogenic disease risk in different populations: A meta-analysis.

Authors:  Bagher Larijani; Javad Mohammadi Asl; Abbas Keshtkar; Najmaldin Saki; Fatemeh Ardeshir Larijani; Fakher Rahim
Journal:  Indian J Hum Genet       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.